These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 22292457
1. Type of desmin expression in cardiomyocytes - a good marker of heart failure development in idiopathic dilated cardiomyopathy. Pawlak A, Gil RJ, Kulawik T, Pronicki M, Karkucińska-Więckowska A, Szymańska-Dębińska T, Gil K, Lagwinski N, Czarnowska E. J Intern Med; 2012 Sep; 272(3):287-97. PubMed ID: 22292457 [Abstract] [Full Text] [Related]
7. Regulation of adverse remodelling by osteopontin in a genetic heart failure model. Psarras S, Mavroidis M, Sanoudou D, Davos CH, Xanthou G, Varela AE, Panoutsakopoulou V, Capetanaki Y. Eur Heart J; 2012 Aug; 33(15):1954-63. PubMed ID: 21525025 [Abstract] [Full Text] [Related]
8. Changes in desmin expression in patients with cardiac diastolic dysfunction and preserved or reduced ejection fraction. Pawlak A, Gil RJ, Nasierowska-Guttmejer AM, Kasprzak JD. Adv Med Sci; 2015 Mar; 60(1):148-55. PubMed ID: 25732530 [Abstract] [Full Text] [Related]
11. Patterns of desmin expression in idiopathic dilated cardiomyopathy are related to the desmin mRNA and ubiquitin expression. Pawlak A, Rejmak-Kozicka E, Gil KE, Ziemba A, Kaczmarek L, Gil RJ. J Investig Med; 2019 Jan; 67(1):11-19. PubMed ID: 30097466 [Abstract] [Full Text] [Related]
12. The effect of cardiac fibrosis on left ventricular remodeling, diastolic function, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy. Karaahmet T, Tigen K, Dundar C, Pala S, Guler A, Kilicgedik A, Cevik C, Mahmutyazicioglu K, Isiklar I, Basaran Y. Echocardiography; 2010 Sep; 27(8):954-60. PubMed ID: 20849483 [Abstract] [Full Text] [Related]
13. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy. Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC. Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658 [Abstract] [Full Text] [Related]
16. Apoptosis-related factors p53, bcl-2 and the defects of force transmission in dilated cardiomyopathy. Tsipis A, Athanassiadou AM, Athanassiadou P, Kavantzas N, Agrogiannis G, Patsouris E. Pathol Res Pract; 2010 Sep 15; 206(9):625-30. PubMed ID: 20591580 [Abstract] [Full Text] [Related]
17. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure. Moorjani N, Westaby S, Narula J, Catarino PA, Brittin R, Kemp TJ, Narula N, Sugden PH. Am J Cardiol; 2009 May 01; 103(9):1261-8. PubMed ID: 19406269 [Abstract] [Full Text] [Related]